Bank Of America Corp Anavex Life Sciences Corp. Put Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$3.39 - $5.02 $1.32 Million - $1.95 Million
-388,800 Reduced 68.85%
175,900 $742,000
Q1 2024

May 15, 2024
BUY
$4.55 - $6.75 $2.57 Million - $3.81 Million
564,700 New
564,700 $2.87 Million
Q4 2022

Feb 10, 2023
BUY
$7.65 - $14.43 $774,180 - $1.46 Million
101,200 New
101,200 $937,000
Q3 2021

Nov 15, 2021
BUY
$16.82 - $25.75 $16,820 - $25,750
1,000 New
1,000 $18,000

Others Institutions Holding AVXL

# of Institutions
152
Shares Held
26.5M
Call Options Held
674K
Put Options Held
811K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $424M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email